Keywords: anti-B PS IgM Ab; anti-serogroup B capsular polysaccharide IgM antibodies; BCA; bactericidal activity test; CFU; colony forming unit; ELISA; enzyme-linked immunosorbent assay; fH; factor H; fHbp; factor H-binding protein; GMT; geometric mean titre; IMD; i
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Neisseria meningitidis; Meningococcal disease; MenB vaccine; Vaccine evaluation; GNA; genome-derived Neisserial antigen; fHbp; factor H-binding protein; NadA; Neisserial adhesin A; NHBA; Neisserial heparin-binding antigen; cc; clonal complex; MenA; serogr
Keywords: Neisseria meningitidis; Vaccine; Complement; Factor H; Factor H-binding protein; Transgenic mouse; OMV; Outer membrane vesicle; Bexsero
Antibody persistence and booster responses 24-36 months after different 4CMenB vaccination schedules in infants and children: A randomised trial
Keywords: Antibody persistence; Meningococcal B vaccine; Infants; Children; Booster response; 2Â +Â 1 schedule; Safety; Open-label randomised clinical trial; AE; adverse event; CI; confidence interval; FAS; full analysis set; fHbp; factor H-binding protein; GMT; ge
Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution
Keywords: Neisseria meningitidis; Factor H-binding protein; Meningococcal vaccines; DNA sequencing;
Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults
Keywords: IMD; invasive meningococcal disease; MenC; serogroup C meningococcal disease; MenB; serogroup B meningococcal disease; MCCV; meningococcal serogroup C conjugate vaccine; MenACWY; serogroups A, C, W, Y meningococcal disease; OMV; outer membrane vesicle; fH
A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: Results of a phase 2 randomized, controlled trial
Keywords: NCT01272180; Conjugate vaccines; Meningococcal; Immunogenicity; Safety; Adolescent; hSBA; serum bactericidal activity with human complement; fHbp; factor H-binding protein; NadA; Neisseria adhesin A; NHBA; Neisserial Heparin Binding Antigen; OMV; outer me
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants
Keywords: Neisseria meningitidis serogroup B; Factor H-binding protein; LP2086; Infants;
A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults
Keywords: (AEs); adverse events; (fHBP also known as rLP2086); factor H-binding protein; (GMT); geometric mean titre; (hSBA); human serum bactericidal assay; (IMD); invasive meningococcal disease; (Mn); meningococcal; (MnB); meningococcal serogroup B; (MnC); mening
fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations
Keywords: fH; factor H; fHbp; factor H-binding protein; NspA; Neisseria surface protein A; Neisseria meningitidis; Vaccine; Complement; Factor H; fHbp; NspA; Transgenic rat;
Neisseria meningitidis serogroup B lipooligosaccharide genotyping reveals high prevalence of L2 strains in Spain and unexpected relationship with factor H-binding protein expression
Keywords: Neisseria meningitidis serogroup B; Lipooligosaccharide; Factor H-binding protein; Polymerase chain reaction;